Health IT PDI moving into molecular diagnostics Advertisement By: Staff Friday, October 17th, 2014 Print Share Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to share on LinkedIn (Opens in new window) Click to email a link to a friend (Opens in new window) PDI announced that its subsidary, Interpace Diagnostics, has acquired Asuragen’s miRInform tests. To read more, click here. AI in healthcare: 4 health systems show what works and what doesn’tRecommended Whitepaper
